• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oasmia Pharmaceutical AB

+ Add to Watchlist


21.5000 SEK 0.2000 0.94%

As of 11:29:59 ET on 08/28/2014.

Snapshot for Oasmia Pharmaceutical AB (OASM)

Open: 21.0000 Day's Range: 21.0000 - 21.5000 Volume: 53,602
Previous Close: 21.3000 52wk Range: 15.4000 - 31.3000 1-Yr Rtn: +26.47%

Stock Chart for OASM

No chart data available.
  • OASM:SS 21.4000
  • 1D
  • 1M
  • 1Y
Interactive OASM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OASM

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) 113.1579
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -1.2800
Est. EPS (SEK) (04/2015) 0.1900
Est. PEG Ratio -
Market Cap (M SEK) 1,893.56
Shares Outstanding (M) 88.07
30 Day Average Volume 42,536
Price/Book (mrq) 6.5263
Price/Sale (ttm) 29,480.8000
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OASM

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for OASM

Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.

Joel Tomas CitronChairmanJulian AleksovCEO/Co-Founder
Hans SundinExecutive Vice PresidentMargareta ErikssonVP:Clinical Development
More Company Profile & Key Executives for OASM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil